addiction and mental health

(Centre for Addiction and Mental Health) The Center for Addiction and Mental Health is proud to announce a landmark investment of $15 million by the Canada Foundation for Innovation.

This contribution, the largest individual grant in CAMH's history, kicks off a $38 million project that will enable CAMH to focus on transforming lives across six research themes: schizophrenia, mood disorders, addictions, community health and knowledge exchange, neuroimaging, pharmacogentics and neuroscience.

The Centre for Addiction and Mental Health has discovered a new form of intellectual disability involving mental retardation along with the eye defect retinitis pigmentosa.

CAMH also discovered the previously unidentified gene that causes this disorder, CC2D2A. This scientific advance will help understand the developmental and biological processes involved in brain development, and may help identify ways to diagnose and treat intellectual disabilities.

Scientists at the Center for Addiction and Mental Health have discovered epigenetic changes in individuals with schizophrenia and bipolar disorder.

This is the first epigenome-wide investigation in psychiatric research, and this groundbreaking data may be a significant step on the journey to fully understanding major psychosis.